Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
Clinical trial NCT00082862 · UNKNOWN
Trial details
- NCT number
- NCT00082862
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2012-11-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.